BARBARA NEFSTEAD: Open Payments
NPI 1568700409 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,864 in 123 payments from 15 companies in 2025. Trend: 2023 $2,397 · 2024 $2,794 · 2025 $3,864
Food & beverage: $3,864
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 12 | $669 |
| Neurocrine BioSciences, Inc. | 23 | $633 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $403 |
| Otsuka America Pharmaceutical, Inc. | 9 | $381 |
| Teva Pharmaceuticals USA, Inc. | 19 | $300 |
| Axsome Therapeutics, Inc. | 5 | $269 |
| ABBVIE INC. | 7 | $224 |
| Alkermes, Inc. | 6 | $216 |
| Lundbeck LLC | 9 | $198 |
| Collegium Pharmaceutical, Inc. | 10 | $173 |
Products named: COBENFY, INGREZZA, REXULTI, CAPLYTA, AUSTEDO XR, Auvelity, VRAYLAR, Jornay PM.
Industry payments across TX — which companies pay providers there.
